Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan.
Sugimoto Y, Nagaharu K, Ohya E, Ohishi K, Tawara I, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Edahiro Y, Hashimoto Y, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N. Sugimoto Y, et al. Among authors: tomita a. Int J Hematol. 2024 Dec;120(6):684-693. doi: 10.1007/s12185-024-03862-5. Epub 2024 Oct 28. Int J Hematol. 2024. PMID: 39467899
Antibody response after third dose of COVID-19 mRNA vaccination in allogeneic hematopoietic stem cell transplant recipients is comparable to that in healthy counterparts.
Takagi E, Terakura S, Fujigaki H, Okamoto A, Miyao K, Sawa M, Morishita T, Goto T, Ozawa Y, Nishida T, Fukushima N, Ozeki K, Hanajiri R, Saito K, Murata M, Tomita A, Kiyoi H. Takagi E, et al. Among authors: tomita a. Int J Hematol. 2023 Oct;118(4):462-471. doi: 10.1007/s12185-023-03648-1. Epub 2023 Aug 10. Int J Hematol. 2023. PMID: 37561340
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study.
Minami Y, Doki N, Matsuoka H, Yokota T, Tomita A, Takahashi N, Kubo K, Goto T, Kirito K, Maki A, Aoki M, Dawson MK, Matsumura I. Minami Y, et al. Among authors: tomita a. Int J Hematol. 2024 Sep;120(3):305-313. doi: 10.1007/s12185-024-03805-0. Epub 2024 Jun 18. Int J Hematol. 2024. PMID: 38888812 Free PMC article. Clinical Trial.
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.
Nagaharu K, Ohya E, Edahiro Y, Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N, Ohishi K, Tawara I, Sugimoto Y. Nagaharu K, et al. Among authors: tomita a. Ann Hematol. 2024 Sep;103(9):3535-3541. doi: 10.1007/s00277-024-05898-3. Epub 2024 Jul 22. Ann Hematol. 2024. PMID: 39037588
Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.
Nagaharu K, Ohya E, Edahiro Y, Hashimoto Y, Ito T, Gotoh A, Nakamae M, Kimura F, Koike M, Kirito K, Wada H, Usuki K, Tanaka T, Mori T, Wakita S, Saito TI, Saito AM, Shimoda K, Kurokawa T, Tomita A, Kiyoi H, Akashi K, Matsumura I, Takenaka K, Komatsu N, Ohishi K, Tawara I, Sugimoto Y. Nagaharu K, et al. Among authors: tomita a. Ann Hematol. 2024 Oct;103(10):4349-4350. doi: 10.1007/s00277-024-05940-4. Ann Hematol. 2024. PMID: 39167184 No abstract available.
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.
Yokota H, Miyao K, Sawa M, Terakura S, Kurahashi S, Ikoma Y, Imahashi N, Morishita T, Okamoto A, Kajiguchi T, Ono T, Narita T, Kanemura N, Ozeki K, Kojima Y, Naito K, Uchino K, Tomita A, Iida H, Imoto N, Kasahara S, Inagaki Y, Nishida T, Murata M. Yokota H, et al. Among authors: tomita a. J Hematol. 2024 Aug;13(4):142-149. doi: 10.14740/jh1289. Epub 2024 Aug 10. J Hematol. 2024. PMID: 39247063 Free PMC article.
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation.
Barakat C, Inagaki Y, Mizuno S, Nishio N, Katsuyama N, Sato Y, Kobayashi M, Ozeki K, Iida H, Tomita A, Sawa M, Demachi-Okamura A, Takahashi Y, Nishikawa H, Akatsuka Y. Barakat C, et al. Among authors: tomita a. Int J Hematol. 2023 Aug;118(2):252-266. doi: 10.1007/s12185-023-03621-y. Epub 2023 Jun 13. Int J Hematol. 2023. PMID: 37310580
Primary large B-cell lymphoma of the central nervous system: A reappraisal of CD5-positive cases based on clinical, pathological, and molecular evaluation.
Yamada S, Satou A, Tsuyuki Y, Iba S, Okumura Y, Ishikawa E, Ito H, Kogure Y, Goto N, Tanikawa M, Shimada K, Tsukamoto T, Karube K, Yokoo H, Kataoka K, Tomita A, Mase M, Nakamura S. Yamada S, et al. Among authors: tomita a. Pathol Int. 2024 Dec 11. doi: 10.1111/pin.13496. Online ahead of print. Pathol Int. 2024. PMID: 39660959
626 results